Dynavax Technologies (DVAX) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to -$647.8 million.
- Dynavax Technologies' Enterprise Value rose 1520.66% to -$647.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$647.8 million, marking a year-over-year increase of 1520.66%. This contributed to the annual value of -$713.8 million for FY2024, which is 383.51% up from last year.
- According to the latest figures from Q3 2025, Dynavax Technologies' Enterprise Value is -$647.8 million, which was up 1520.66% from -$613.7 million recorded in Q2 2025.
- Over the past 5 years, Dynavax Technologies' Enterprise Value peaked at -$232.7 million during Q1 2021, and registered a low of -$764.0 million during Q3 2024.
- In the last 5 years, Dynavax Technologies' Enterprise Value had a median value of -$647.8 million in 2025 and averaged -$601.4 million.
- As far as peak fluctuations go, Dynavax Technologies' Enterprise Value tumbled by 23080.66% in 2021, and later skyrocketed by 1656.89% in 2025.
- Over the past 5 years, Dynavax Technologies' Enterprise Value (Quarter) stood at -$545.9 million in 2021, then decreased by 14.37% to -$624.4 million in 2022, then dropped by 18.88% to -$742.3 million in 2023, then increased by 3.84% to -$713.8 million in 2024, then increased by 9.25% to -$647.8 million in 2025.
- Its Enterprise Value was -$647.8 million in Q3 2025, compared to -$613.7 million in Q2 2025 and -$661.3 million in Q1 2025.